Imiquimod in the treatment of extensive recurrent lentigo maligna

J Am Acad Dermatol. 2005 Feb;52(2 Suppl 1):51-2. doi: 10.1016/j.jaad.2004.07.047.

Abstract

We report the case of a 70-year-old white male with an extensive recurrence of lentigo maligna in a skin-transplanted region. He was treated with imiquimod 5% cream topically applied 5 times a week for a total duration of 9 months. Clinically and histologically, a complete clearing of the lesion was observed after treatment. Topical treatment with imiquimod seems to be effective and safe in lentigo maligna.

Publication types

  • Case Reports

MeSH terms

  • Administration, Cutaneous
  • Aged
  • Aminoquinolines / therapeutic use*
  • Antineoplastic Agents / therapeutic use*
  • Facial Neoplasms / drug therapy*
  • Facial Neoplasms / pathology
  • Humans
  • Hutchinson's Melanotic Freckle / drug therapy*
  • Hutchinson's Melanotic Freckle / pathology
  • Imiquimod
  • Male
  • Neoplasm Recurrence, Local / drug therapy*
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / pathology

Substances

  • Aminoquinolines
  • Antineoplastic Agents
  • Imiquimod